Business / WORLD

Sonova raises annual outlook after hearing instrument sales lift half-year profit

The Swiss hearing technology group reported CHF1.83 billion in first-half sales and raised its 2026/27 guidance. Growth was strongest in hearing instruments, while the company separately reported pressure in cochlear implants and losses tied to discontinued consumer hearing operations.

Reading sizeSources ↓Share story ↗
Conceptual illustration of industry, engineering and logistics connections.Illustration
Symbolic illustration

Sonova reported first-half sales of CHF1.834 billion for the six months ended 30 September 2026, up 7.5 per cent in local currencies and 6.7 per cent in Swiss francs. The Swiss hearing solutions group said its hearing instruments business gained share in wholesale channels for an 11th consecutive quarter. On 12 November it raised its full-year 2026/27 sales growth outlook to 6 to 8 per cent and its core EBIT growth range to 10 to 13 per cent, both measured in local currencies.

Hearing instruments generated CHF1.717 billion in sales, rising 8.2 per cent in Swiss francs and 9.0 per cent in local currencies. Wholesale sales increased 10.0 per cent in Swiss francs, while retail sales grew 6.0 per cent. Sonova attributed the performance to higher volumes, average selling price gains, market share progress and product launches including Virto R and EON. These are company-reported explanations; the release does not separate the contribution of each product or customer contract to growth.

Profitability improved faster than revenue. Reported EBIT reached CHF372.0 million, compared with CHF279.9 million a year earlier. Core EBIT was CHF384.0 million, up 21.4 per cent in Swiss francs and 22.9 per cent in local currencies. The core EBIT margin expanded to 20.9 per cent from 18.4 per cent. Core figures exclude selected items under the company’s non-GAAP definitions, so they should not be compared directly with reported figures without the reconciliation in the financial report.

Regional sales were broad-based in the company’s account. EMEA and Latin America generated CHF992.9 million, North America CHF654.3 million and Asia Pacific CHF186.9 million. Sales grew 6.4 per cent in Swiss francs in EMEA and Latin America, 5.8 per cent in North America and 11.9 per cent in Asia Pacific. Foreign exchange movements reduced total reported sales by CHF13.7 million and lowered Swiss franc growth by 0.8 percentage points. That distinction helps separate underlying local-currency growth from the conversion effect.

The picture was not uniform across product lines. Sonova said performance in cochlear implants remained pressured, particularly in China and the United States, while growth in hearing instruments drove the overall increase. The company reported that the cochlear implant segment’s operating environment weighed on performance. A strong group result therefore does not imply that every product category or market expanded. Investors and customers assessing the sector need segment-level data rather than extrapolating the headline sales increase across all hearing technologies.

Sonova also reports consumer hearing as discontinued operations following its announced intention to divest that business. It recorded CHF114.8 million in sales from those operations during the half year and a CHF56.8 million after-tax loss. That loss included a CHF68.3 million write-down to fair value less costs to sell and a related CHF12.1 million tax effect. The discontinued business is presented separately from continuing operations, which affects comparisons of earnings per share and group profitability.

The raised outlook is a forward-looking company estimate, not a completed result. Sales growth guidance moved from a previous range of 5 to 8 per cent to 6 to 8 per cent, and core EBIT growth guidance from 7 to 10 per cent to 10 to 13 per cent. Both use local currency. Exchange rates, demand, product execution and competition can affect the reported Swiss franc result, and the company’s guidance is subject to the assumptions and risks in its announcement.

The first-half report links growth to product launches, geographic expansion and operating efficiency programmes. It describes ongoing retail expansion and investment, as well as efforts to improve planning, manufacturing reliability and automation. Sonova said it remained on track toward targeted operational savings of CHF90 million. Those savings are a target and not a current-period cash benefit; the release does not provide a full breakdown of realised savings versus planned actions.

For the hearing care market, the result illustrates how a company can combine wholesale devices, retail services and a broader product portfolio. The revenue mix matters because distribution and product channels have different operating economics. Sonova’s growth in wholesale hearing instruments and retail services points to multiple sources of expansion, while lower cochlear implant performance remains a counterweight. The release offers company-level segment data, but not independent market share estimates for all regions or competitors.

The confirmed result is higher first-half revenue and core operating profit, supported chiefly by hearing instruments, followed by a raised annual outlook. Reported and adjusted figures tell different parts of the story, and discontinued consumer hearing operations affected the total presentation. The guidance should be tracked against audited full-year results rather than treated as guaranteed. The key uncertainties include the performance of cochlear implants, currency movements and whether the commercial and efficiency initiatives deliver the targeted returns.

Data

Table

Reported results and measures

Selected figures transcribed from the primary source.

First-half salesCHF 1,834.1 million, up 6.7% in Swiss francs and 7.5% in local currencies.
Core EBITCHF 384.0 million, up 21.4% in Swiss francs; core margin 20.9%.
Hearing instruments salesCHF 1,716.7 million, up 8.2% in Swiss francs.
2026/27 guidanceSales growth 6% to 8%; core EBIT growth 10% to 13%, both in local currencies.
Methodology

Figures are reproduced from the cited source. They retain its stated period, scope and definitions; any derived calculation is identified in the article.

Updated:

Structured coverage

Subjects and places

Subject proposals

Geographic references

Only source-provided geographic references are shown. Opening an external map is optional. Optional story maps use OpenStreetMap. Opening a map sends your IP address and this site’s address to the map provider; location data remains readable as text without loading the map.

  • Switzerland · Place role: Coverage · Place type: Country or area · Location precision: Regional
    Evidence
    • Explicit preserved editorial country/region; no city or national centroid inferredwww.sonova.com ↗
Taxonomy version: IPTC Media Topics 2026-Q2

Continue reading